Hovione
Sarang Oka is an accomplished professional in the field of continuous manufacturing and process development, currently serving as a Fellow in Continuous Tableting and Senior Manager of Drug Product Continuous Manufacturing at Hovione since April 2017. Prior to this role, Sarang held positions including Manager of Continuous Manufacturing Process Development and Process Development Engineer at Hovione. Academic experience includes postdoctoral research at Rutgers University from September 2011 to April 2017, where Sarang also served as a Graduate Assistant. Additional research experience includes visiting researcher roles at VŠCHT Praha - UCT Prague in 2013 and 2015. Early career experience includes internships at Glatt Group and Stepan Company. Sarang holds a PhD in Chemical and Biochemical Engineering from Rutgers University and a Bachelor of Engineering in Chemical Engineering from the University of Mumbai.
This person is not in any teams
This person is not in any offices
Hovione
2 followers
Hovione is an international company with over 60 years of experience in pharmaceutical development and manufacturing operations. As a Contract Development and Manufacturing Organization (CDMO) with a fully integrated offering of services for drug substances, drug product intermediates and drug products. The company has four FDA inspected sites in the USA, Portugal, Ireland and China and development laboratories in Lisbon, Portugal and New Jersey, USA. Hovione provides pharmaceutical customers services for the development and compliant manufacture of innovative drugs, including highly potent compounds, and customized product solutions across the entire drug life cycle. In the inhalation area, Hovione offers a complete range of services, from API, formulation development and devices. Hovione´s culture is based on innovation, quality and dependability. Hovione was the first Chemical/ Pharmaceutical Company to become a Certified B Corp, is a member of Rx-360, EFCG and participates actively in industry quality improvement initiatives to lead new global industry standards.